Alvotech And Stada Gain Second Ever Higher-Strength Adalimumab Nod
Hukyndra And Libmyris Biosimilar Rivals To Humira Endorsed By EMA’s CHMP
Alvotech and Stada are on the verge of gaining the world’s second ever approval for a higher-strength Humira biosimilar, after the EMA’s CHMP endorsed the firms’ adalimumab under the names Hukyndra and Libmyris at its September meeting.
